Dallas, TX - The Publisher of Daily
OTC Stocks Newsletter (http://www.otcpicks.com/hotpicks.htm ) and Free Red Hot Stock Picks presents the following penny stocks to watch tomorrow: SOHM Inc. (OTC: SHMN), SciMeDent Health Corp. (OTC: TRDX) and Cypress Bioscience Inc. (Nasdaq: CYPB).SOHM INCORPORATED (OTC: SHMN) "Up 33.33% on Monday"
SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters is located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia.
SCIMEDENT HEALTH CORPORATION (OTC: TRDX) "Up 74.13% on Monday"
SciMeDent (www.scimedenthealth.com), formerly known as Trend Exploration, is a company focused on being a leading developer and marketer of products and services for medicine, dentistry and life sciences. SciMeDent plans to achieve growth initially through mergers and acquisitions.
CYPRESS BIOSCIENCE INCORPORATED (NASDAQ: CYPB) "Up 34.00% on Monday"
Cypress Bioscience, Inc. provides therapeutics and personalized medicine services in the United States. The company focuses on addressing the needs of physicians and their patients by identifying unmet medical needs in the areas of pain, rheumatology, and physical medicine and rehabilitation, including challenging disorders, such as fibromyalgia and rheumatoid arthritis. It offers Savella, a dual-reuptake inhibitor that preferentially blocks the reuptake of norepinephrine for the management of fibromyalgia. The company also provides personalized medicine services, including Avise MCV, a test that aids in the diagnosis and prognosis of rheumatoid arthritis; and Avise PG, a test that supports dose optimization and therapeutic decision making for patients taking methotrexate. Cypress Bioscience, Inc. has a license agreement with Pierre Fabre Medicament to develop and sell products with the compound milnacipran as an active ingredient for various indications in the United States and Canada; and a collaboration agreement with Forest Laboratories, Inc. for the development and marketing of milnacipran. The company was founded in 1981 and is based in San Diego, California.
The stocks presented above are available in OTCPicks.com's Free Daily Email Newsletter. For daily
penny stock alerts go to http://www.otcpicks.com/hotpicks.htmGet the latest updates via Twitter at
www.twitter.com/otcpicks or through Facebook - www.facebook.com/otcpicks.Disclosure: OTCPicks has not been compensated by any of the companies covered in this release.
